ConductScience.org, home

Paper42979487PubMed

Key Players and Pathways of Mast Cell Activation in Urticaria.

Jahn C and 4 others. J Inflamm Res, 2026.

Cite this record

ConductScience Library. Key Players and Pathways of Mast Cell Activation in Urticaria. Papers, record 42979487. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/42979487

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Key Players and Pathways of Mast Cell Activation in Urticaria.
Journal
J Inflamm Res
Year
2026
Publication types
Journal Article, Review
Revised in PubMed
2026-11-05

Source PubMed

Authors5

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

Source PubMed

Download CSV of authors

Topics0

NLM's MeSH indexing of the paper, its major topics first.

None in this release.

References179

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
18675625Serum IgG autoantibodies directed against the alpha chain of Fc epsilon RI: a selective marker and pathogenetic factor for a distinct subset of chronic urticaria patients?J Clin Invest1995https://conductscience.org/library/papers/8675625PubMed
224954276Expression of Mas-related gene X2 on mast cells is upregulated in the skin of patients with severe chronic urticaria.J Allergy Clin Immunol2014https://conductscience.org/library/papers/24954276PubMed
338533368Levels of serum inflammatory cytokines and their correlations with disease severity in patients with chronic spontaneous urticaria.Postepy Dermatol Alergol2024https://conductscience.org/library/papers/38533368PubMed
434808483Thrombin induces pro-inflammatory and anti-inflammatory cytokines secretion from human mast cell line (HMC-1) via protease-activated receptors.Mol Immunol2022https://conductscience.org/library/papers/34808483PubMed
540782271Autoallergy and what the Allergist Needs to know.Curr Allergy Asthma Rep2025https://conductscience.org/library/papers/40782271PubMed
637506162The correlation between Th17/Treg immune dysregulation and the disease severity in chronic spontaneous urticaria patients.Immun Inflamm Dis2023https://conductscience.org/library/papers/37506162PubMed
715010370NTAL phosphorylation is a pivotal link between the signaling cascades leading to human mast cell degranulation following Kit activation and Fc epsilon RI aggregation.Blood2004https://conductscience.org/library/papers/15010370PubMed
810447728Evaluation of C3a receptor expression on human leucocytes by the use of novel monoclonal antibodies.Immunology1999https://conductscience.org/library/papers/10447728PubMed
918802362Expression of tissue factor by eosinophils in patients with chronic urticaria.Int Arch Allergy Immunol2009https://conductscience.org/library/papers/18802362PubMed
1028389391Omalizumab is effective in symptomatic dermographism-results of a randomized placebo-controlled trial.J Allergy Clin Immunol2017https://conductscience.org/library/papers/28389391PubMed
1141914312Immunological Basis of Chronic Spontaneous Urticaria: Immunoglobulin E and Beyond.Yonsei Med J2026https://conductscience.org/library/papers/41914312PubMed
1228303277Basophil FcεRI Expression in Chronic Spontaneous Urticaria: A Potential Immunological Predictor of Response to Omalizumab Therapy.Acta Derm Venereol2017https://conductscience.org/library/papers/28303277PubMed
1320613776Cholinergic urticaria: studies on the muscarinic cholinergic receptor M3 in anhidrotic and hypohidrotic skin.J Invest Dermatol2010https://conductscience.org/library/papers/20613776PubMed
1430651343Angiogenic Host Defense Peptide AG-30/5C and Bradykinin B2 Receptor Antagonist Icatibant Are G Protein Biased Agonists for MRGPRX2 in Mast Cells.J Immunol2019https://conductscience.org/library/papers/30651343PubMed
1520203527Heparin and tranexamic Acid therapy may be effective in treatment-resistant chronic urticaria with elevated d-dimer: a pilot study.Int Arch Allergy Immunol2010https://conductscience.org/library/papers/20203527PubMed
1641967676Clinical Evolution of Acute Urticaria and Association With IgE Autoantibodies.J Allergy Clin Immunol Pract2026https://conductscience.org/library/papers/41967676PubMed
1716785568Fc gamma RIIa, not Fc gamma RIIb, is constitutively and functionally expressed on skin-derived human mast cells.J Immunol2006https://conductscience.org/library/papers/16785568PubMed
1832888945Coagulation factors induce human skin mast cell and basophil degranulation via activation of complement 5 and the C5a receptor.J Allergy Clin Immunol2021https://conductscience.org/library/papers/32888945PubMed
1917827066Hyperexpression of FcgammaRI and Toll-like receptor 4 in the intestinal mast cells of Crohn's disease patients.Clin Immunol2007https://conductscience.org/library/papers/17827066PubMed
2041005705Efficacy, Safety, and Quality-of-Life Outcomes of Remibrutinib in Chronic Spontaneous Urticaria: A Systematic Review and Meta-Analysis.J Allergy Clin Immunol Pract2025https://conductscience.org/library/papers/41005705PubMed

See all 179 referencesDownload CSV of references

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • Cited by
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/42979487

GET https://conductscience.org/api/papers/v1/42979487/references?page=2